162
Views
3
CrossRef citations to date
0
Altmetric
Research Article

The association between serum progesterone and outcome of medical management of early fetal demise: A pilot study

, &
Pages 384-386 | Published online: 08 May 2013

References

  • Banerjee S, Aslam N, Woelfer B, Lawrence A, Elson J, Jurkovic D. 2001. Expectant management of early pregnancies of unknown location: a prospective evaluation of methods to predict spontaneous resolution of pregnancy. British Journal of Obstetrics and Gynaecology 108: 158–163.
  • Elson J, Salim R, Tailor A, Banerjee S, Zosmer N, Jurkovic D. 2003. Prediction of early pregnancy viability in the absence of an ultrasonically detectable embryo. Ultrasound in Obstetrics and Gynecology 21:57–61.
  • Gravanis A, Schaison G, George M, de Brux J, Satyaswaroop PG, Baulieu EE et al. 1985. Endometrial and pituitary responses to steroidal Antiprogestin RU 486 in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 60:156–163.
  • Hahlin M, Sjoblom P, Lindblom B. 1991. Combined use of progesterone and human chorionic gonadotropin determinations for differential diagnosis of very early pregnancy. Fertility and Sterility 55:492–496.
  • Hapangama DK. 2003. Mifepristone: the multifaceted antihormone. Journal of Drug Evaluation 1:149–175.
  • Loose DS, Stancel GM. 2006. Hormones and Hormone Antagonists. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman and Gilman's The pharmacological basic of therapeutics. 11th ed. New York: McGraw-Hill. pp. 1541–1571.
  • McCord ML, Muram D, Buster JE, Arheart KL, Stovall TG, Carson SA. 1996. Single serum progesterone as a screen for ectopic pregnancy: exchanging specificity and sensitivity to obtain optimal test performance. Fertility and Sterility 66:513–516.
  • Nielsen S, Hahlin M, Platz-Christensen JJ. 1997. Unsuccessful treatment of missed abortion with a combination of an antiprogesterone and a prostaglandin E1 analogue. British Journal of Obstetrics and Gynaecology 104:1094–1096.
  • RCOG. 2006. The management of early pregnancy loss. Royal College of Obstetricians and Gynaecologists: Guideline No. 25. London: RCOG Press.
  • Rozenberg P, Chevret S, Camus E, de Tayrac R, Garbin O, de Poncheville L et al. 2003. Medical treatment of ectopic pregnancies: a randomized clinical trial comparing methotrexate-mifepristone and methotrexate-placebo. Human Reproduction 18:1802–1808.
  • Sarkar NN. 2002. Mifepristone: bioavailability, pharmacokinetics and use-effectiveness. European Journal of Obstetrics and Gynecology and Reproductive Biology 101:113–120.
  • Tang OS, Gemzell-Danielsson K, Ho PC. 2007. Misoprostol: Pharmacokinetic profiles, effects on the uterus and side-effects. International Journal of Gynecology and Obstetrics 99:S160–S167.
  • Wagaarachchi PT, Ashok PW, Narvekar N, Smith NC, Templeton A. 2001. Medical management of early fetal demise using a combination of mifepristone and misoprostol. Human Reproduction 16:1849–1853.
  • Zalanyi S. 1998. Vaginal misoprostol alone is effective in the treatment of missed abortion. British Journal of Obstetrics and Gynaecology 105:1026–1028.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.